Intelligence · Clinical Development
Pipeline search results
Programs matching “amphetamine” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 53 pipeline programs matching "amphetamine" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
811095
BRIGHT MINDS BIOSCIENCES INC.
Amphetamine Dependence
1 trial -
Mixed salts of a single-entity amphetamine
Takeda
Attention Deficit Disorder With Hyperactivity
1 trial -
Mixed salts of a single-entity amphetamine (ADDERALL XR)
Takeda
ADHD
1 trial -
SPD465-303
Takeda
Attention Deficit Disorder With Hyperactivity
4 trials -
extended-release naltrexone (XR-NTX)
BRIGHT MINDS BIOSCIENCES INC.
Methamphetamine-dependence
1 trial -
18-0254
BRIGHT MINDS BIOSCIENCES INC.
Methamphetamine Use Disorder
1 trial -
3,4-Methylenedioxymethamphetamine (MDMA)
United Therapeutics Europe Ltd
Post Traumatic Stress Disorder
1 trial -
Atomoxetine
BRIGHT MINDS BIOSCIENCES INC.
Methamphetamine Dependence
1 trial -
Behavior Therapy
BRIGHT MINDS BIOSCIENCES INC.
The Study Was Designed to Develop a Cognitive Behavioral Approach to Treating Methamphetamine Abuse in HIV Primary Care Settings
1 trial -
Bupropion
BRIGHT MINDS BIOSCIENCES INC.
Amphetamine-Related Disorders
2 trials -
Bupropion
BRIGHT MINDS BIOSCIENCES INC.
Methamphetamine
1 trial -
Bupropion
BRIGHT MINDS BIOSCIENCES INC.
Methamphetamine Dependence
1 trial -
Bupropion SR 150mg tabs
BRIGHT MINDS BIOSCIENCES INC.
Adolescent Methamphetamine Abuse
1 trial -
CPP-109 vigabatrin
CATALYST PHARMACEUTICALS, INC.
Methamphetamine Dependence
1 trial -
D-Amphetamine 30mg
BRIGHT MINDS BIOSCIENCES INC.
Cocaine-Related Disorders
1 trial -
Dextro-Amphetamine Sulfate
BRIGHT MINDS BIOSCIENCES INC.
Cocaine-Related Disorders
1 trial -
Dextroamphetamine
BRIGHT MINDS BIOSCIENCES INC.
Cocaine-Related Disorders
4 trials -
Doxazosin extended release
BRIGHT MINDS BIOSCIENCES INC.
Methamphetamine or Cocaine Dependence
1 trial -
Ibudilast
BRIGHT MINDS BIOSCIENCES INC.
Methamphetamine Dependence
1 trial -
Intermittent Oral Naltrexone
BRIGHT MINDS BIOSCIENCES INC.
Methamphetamine
1 trial -
Methamphetamine
BRIGHT MINDS BIOSCIENCES INC.
Methamphetamine Intoxication
1 trial -
Mirtazapine
BRIGHT MINDS BIOSCIENCES INC.
Amphetamine-Related Disorders
1 trial -
Mixed-Amphetamine Salts- Extended Release (MAS-ER)
BRIGHT MINDS BIOSCIENCES INC.
Cocaine Dependence
1 trial -
Modafinil
BRIGHT MINDS BIOSCIENCES INC.
Methamphetamine Dependence
2 trials
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.